Trial reportEuropean radiology2026
Artificial intelligence-assisted reading of non-contrast prostate MRI: application and concordance with expert interpretation in a screening population within the PROSA trial.
Trial report in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Contrast-free MRI-first screening in young asymptomatic men: Prostate characteristics and cancer detection rates.Prostate cancer and prostatic diseases · 2026Article
- Integrating Artificial Intelligence into Prostate MR Imaging: Technical Foundations, Clinical Applications, and Workflow Implications.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026Review
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
11 authors.
Funding
Abstract
objectivesNon-contrast MRI (bi-parametric MRI-bpMRI) has been investigated as a potential tool to be integrated in clinically significant prostate cancer (csPCa) screening. Moreover, artificial intelligence (AI) is emerging too as a potential support, especially for less-experienced radiologists. Therefore, the aim of this study was to evaluate the effectiveness of an AI-based software in csPCa screening using bpMRI, with a focus on supporting less-experienced radiologists. MATERIAL AND
methodsA retrospective analysis was conducted within the PROSA-trial, a randomized, single-center study involving 759 men eligible for PCa screening. BpMRI were acquired using prostate imaging reporting and data system (PI-RADS) v2.1-compliant protocols and evaluated independently by an expert radiologist, a less-experienced reader, AI-based software, and the less-experienced reader with AI support. Diagnostic performance was assessed using ROC curves and inter-reader agreement (Cohen's kappa), using expert interpretation as the reference standard.
resultsFour hundred ninety-nine bpMRI were analyzed. The AI-assisted less-experienced reader achieved the highest diagnostic performance (sensitivity 76.5%, specificity 97.2%, accuracy 95.8%, AUC 0.969), surpassing both AI-alone (sensitivity 58.8%, specificity 96.6%, accuracy 94.0%, AUC 0.952) and unaided less-experienced reader (sensitivity 67.6%, specificity 95.1%, accuracy 93.2%, AUC 0.932). Inter-reader agreement improved with AI assistance (from κ = 0.64 to 0.84). AI assistance reduced equivocal PI-RADS 3 cases (from 77 to 53) and improved exact agreement with the expert from 32.5% to 54.5%, while also reducing diagnostic discordance.
conclusionsAI can support less experienced radiologists and enhance consistency in bpMRI interpretation, especially considering equivocal cases. Moreover, integrating AI into radiology workflows can alleviate reporting burden and help prioritize suspicious cases, offering critical advantages in high-volume PCa screening settings. KEY POINTS: Question Can AI improve the diagnostic performance and consistency of less experienced radiologists interpreting non-contrast prostate MRI in a screening setting? Findings AI assistance significantly improved effectiveness and inter-reader agreement in prostate MRI interpretation, particularly for less experienced radiologists within a screening population. Clinical relevance Integrating AI into prostate MRI workflows may enhance screening efficiency, reduce variability, and support equitable early detection of csPCa, with a positive impact on prioritization of reporting.
Indexed as
Identifiers
41686238What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.